117 related articles for article (PubMed ID: 7525089)
1. [A comparative study of the expression of ras oncogenic protein P21 and oncofetal protein AFP, CEA in human hepatocellular carcinoma (HCC)].
Zhang XL; Shi JQ; Zuo SH
Zhonghua Bing Li Xue Za Zhi; 1994; 23(3):155-8. PubMed ID: 7525089
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
[TBL] [Abstract][Full Text] [Related]
3. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
[TBL] [Abstract][Full Text] [Related]
4. Alpha fetoprotein and carcinoembryonic antigen producing hepatocellular carcinoma. A case report studied by immunohistochemistry.
Amano S; Kataoka H; Hazama F; Nakatake M; Maki A
Acta Pathol Jpn; 1985 Jul; 35(4):969-74. PubMed ID: 2416187
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
6. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Lopez JB; Balasegaram M; Timor J; Thambyrajah V
Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
[TBL] [Abstract][Full Text] [Related]
7. [The expression of ras p21 product in hepatocellular carcinoma].
Takeuchi T; Kagawa K; Hikita H; Tada H; Deguchi T; Okanoue T; Kashima K; Yonemura Y; Ueda K; Ashihara T
Nihon Shokakibyo Gakkai Zasshi; 1990 Aug; 87(8):1686-91. PubMed ID: 1700176
[TBL] [Abstract][Full Text] [Related]
8. Do CA 19-9 and TPA play a minor role as compared to AFP in diagnosing primary hepatocellular carcinoma?
Leandro G; Zizzari S; Fabris C; Basso D; Elba S; Del Favero G; Meggiato T; Angonese C; Di Mario F; Manghisi OG
Oncology; 1989; 46(6):381-5. PubMed ID: 2479897
[TBL] [Abstract][Full Text] [Related]
9. [Carcino-fetal antigens].
Endo Y
Nihon Rinsho; 1996 Jun; 54(6):1499-504. PubMed ID: 8691600
[TBL] [Abstract][Full Text] [Related]
10. Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.
Wang X; Zhou Y; Ying X; Guo L; Zhao Y; Fang Y
Clin Chim Acta; 2007 Apr; 379(1-2):158-62. PubMed ID: 17250819
[TBL] [Abstract][Full Text] [Related]
11. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
12. Alpha-fetoprotein in hepatocellular carcinoma: a serological and histochemical study in Malaysian patients.
Yap SF; Peh SC
Malays J Pathol; 1991 Dec; 13(2):115-8. PubMed ID: 1726642
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of primary and metastatic clear cell tumors in the liver by in situ hybridization for albumin messenger RNA.
Oliveira AM; Erickson LA; Burgart LJ; Lloyd RV
Am J Surg Pathol; 2000 Feb; 24(2):177-82. PubMed ID: 10680884
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Chu PG; Ishizawa S; Wu E; Weiss LM
Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
[TBL] [Abstract][Full Text] [Related]
15. [Microspectrophotometric analysis of nuclear DNA contents related to the presence of alpha-fetoprotein in human hepatocellular carcinoma].
Kobayashi K; Yamashita Y; Kamachi M; Kurohiji T; Horiuchi H; Yanase Y; Kakegawa T
Gan To Kagaku Ryoho; 1994 May; 21 Suppl 1():95-101. PubMed ID: 7515615
[TBL] [Abstract][Full Text] [Related]
16. [A comparison study of immunohistochemical detection of ras P21 and N-ras mRNA in situ hybridization in hepatocellular carcinoma and pericancerous nontumor liver tissue].
Bu H
Zhonghua Bing Li Xue Za Zhi; 1991 Mar; 20(1):11-3. PubMed ID: 1648455
[TBL] [Abstract][Full Text] [Related]
17. [The significance of immunohistochemistry in the investigation of liver neoplasms: differential diagnosis, prognostic markers].
Pozharisskiĭ KM; Granov DA; Ten VP; Kubaĭbergenova AG; Leenman EE; Rasskazov AI
Vopr Onkol; 2008; 54(4):417-33. PubMed ID: 18942395
[TBL] [Abstract][Full Text] [Related]
18. A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
Fu X; Tan L; Liu S; Li H; Chen L; Qin J; Wu M; Wang H
J Cancer Res Clin Oncol; 2004 Sep; 130(9):514-20. PubMed ID: 15221469
[TBL] [Abstract][Full Text] [Related]
19. [Expression of p21 in hepatocellular carcinoma and liver cirrhosis and its relation with HBV infection].
Ren CS
Zhonghua Bing Li Xue Za Zhi; 1991 Jun; 20(2):88-90. PubMed ID: 1655296
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
